Updated Visitor Restriction Policy

Effective Monday, April 5, 2021, Rutland Regional has updated the visitation policy to allow for limited visitation. Please read the full policy before coming to the hospital or one of the clinics:

Visitor Restriction Policy

Skip to Content

Lung-Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination

Objective

ECOG E5508 A Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

Lung: The purpose of this study is to find out the best maintenance therapy for patients with advanced stage non-small cell lung cancer. Maintenance therapy is usually given after standard chemotherapy to keep the disease under control for a longer duration. This study will compare the effects, good and/or bad, of the drugs, bevacizumab, pemetrexed or the combination of the two agents when given as maintenance therapy.

Contact
Rebecca Denofer, RN, OCN at 802-747-1692
or rdenofer@rrmc.org

RUTLAND REGIONAL MEDICAL CENTER160 Allen Street, Rutland, VT 05701802.775.7111

© 2021 Rutland Medical Center